Pathpoint makes the routing decision visible
Pathpoint isn’t just a form that returns a price. It describes itself as a full-service E&S wholesaler with a visible fork in the workflow: supported risks reach automated underwriting, while qualifying larger or more complex risks move to human brokerage. That’s genuinely useful if you want the same portal to classify the submission and carry an eligible account forward.
Nomos starts with the file instead of a product workflow. Its site tells you to send what you have so a broker can read the exposure, test it against current appetite, and flag what’s missing. That’s the clearer opening when the submission is ambiguous, spans specialty exposures, or just doesn’t reduce cleanly to a class code and an eligibility screen.
Neither starting point proves the outcome on its own. A supported interface doesn’t guarantee eligibility or a quote, and broker-led appetite review doesn’t guarantee carrier access or placement.
An instant quote and a referral are different products
Pathpoint’s quoting guide says you complete and review a portal submission, then find out whether the risk is instant quotable, referred to an underwriter, or declined. For an eligible risk, the instant lane is a real advantage — you can get a bindable quote and request binding right through the platform. That’s more than digital intake.
The distinction matters just as much when automation stops. Pathpoint’s Middle Market-Brokerage guidance says larger or more complex eligible accounts can get a completeness review before the team forwards the submission to the right carriers. That’s wholesale brokerage, not a delayed version of the instant product — and the guide notes that only some brokerage options actually show up in the app, so never assume “referred” applies to every risk automation can’t quote.
Let the account choose the model
Pathpoint is the clearer route when eligibility is well defined and the portal can carry the account from application through quote review, a binding request and documents. Its upload and prefill features cut down re-entry, but you’re still on the hook for checking the completed application.
Nomos is the clearer route when the first useful answer isn’t a price but a broker’s read on the risk — what the file says, what it leaves unanswered, and which direction is credible. Starting with an existing file avoids forcing an unusual exposure into the wrong product screen, though an insurer may still ask for applications or supplementals later.
The decision gets concrete once you can answer four things: what result Pathpoint can actually reach for this risk, what Nomos would do with the same file, which action actually sends data to insurers, and where service happens after binding. Those answers matter more than whether the wholesaler calls itself digital or traditional.